Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 42,164 | 4,256 | 1,966 | 0 | 0 |
| Cost of Goods | 3,945 | 587 | 324 | N/A | N/A |
| Gross Profit | 38,219 | 3,669 | 1,642 | N/A | N/A |
| Operating Expenses | 59,132 | 66,823 | 53,222 | 31,653 | 22,824 |
| Operating Income | -19,968 | -62,567 | -51,256 | -31,653 | -22,824 |
| Other Income | -1,828 | 1,178 | 1,566 | 774 | 325 |
| Pre-tax Income | -21,796 | -61,389 | -49,690 | -30,879 | -22,499 |
| Net Income Continuous | -21,796 | -61,389 | -49,690 | -30,879 | -22,499 |
| Net Income | $-21,796 | $-61,389 | $-49,690 | $-30,879 | $-22,499 |
| EPS Basic Total Ops | -0.55 | -1.59 | -1.60 | -1.23 | -1.13 |
| EPS Basic Continuous Ops | -0.55 | -1.59 | -1.60 | -1.23 | -1.13 |
| EPS Diluted Total Ops | -0.55 | -1.59 | -1.60 | -1.23 | -1.13 |
| EPS Diluted Continuous Ops | -0.55 | -1.59 | -1.60 | -1.23 | -1.13 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -1.59 | -1.60 | -1.23 | -1.13 |
| EBITDA(a) | $-14,972 | $-60,457 | $-50,630 | $-31,016 | $-22,395 |